Skip to main content

Day: March 15, 2024

Bondholders of Baltic Horizon Fund approved the amendments to the bond terms and conditions

Baltic Horizon Fund applied for bondholders’ approval for certain amendments to the terms and conditions (the Terms and Conditions) of the Baltic Horizon Fund EUR 42 million 5-year floating rate bonds maturing in 2028 (ISIN EE3300003235, the Bonds) and temporary waiver of debt service coverage ratio covenant in relation to the Bonds by way of written procedure announced on 13 March 2024. Bondholders who were entered in the registry of bond-holders maintained by Nasdaq CSD SE on 12 March 2024 were entitled to vote in the written procedure (the Holders). A notice by Triniti Collateral Agent IX OÜ acting as the agent for Holders was sent to the Holders on 13 March 2024. Altogether Holders holding in aggregate Bonds with the nominal value of EUR 34,499,997 which constitutes 100% of the aggregate nominal value of all Bonds, participated in...

Continue reading

FEMSA Announces Accelerated Share Repurchase Agreement

MONTERREY, Mexico, March 15, 2024 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) today announced that, consistent with its capital allocation framework and commitment to enhance capital returns to shareholders, it has entered into a derivative instrument known as an accelerated share repurchase (“ASR”) agreement with a financial institution in the United States of America, to repurchase the Company’s shares through the acquisition of American Depositary Shares (“ADS”). Under the terms of the ASR agreement, FEMSA has agreed to repurchase from such financial institution an aggregate amount of USD $400 million of its ADS1. The ASR contemplates an initial delivery of approximately 20% of the ADS on or about March 19, 2024. The total number of ADS ultimately...

Continue reading

American Rebel Announces $19.9+ Million Public 8.53% Preferred Offering – Updated

Nashville, TN, March 15, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), is pleased to announce the launch of a Regulation A+, equity financing of up to $19,999,995 of 8.53% Series C Redeemable Convertible Preferred Stock (the “Public Offering”). This Public Offering is a watershed event for the Company and allows anyone 18 years or older to log onto the American Rebel Public Offering website at https://invest.americanrebel.com/ and with a click of a button subscribe to the offering. A copy of the Company’s offering circular for the Public Offering has been posted at https://www.sec.gov/Archives/edgar/data/1648087/000149315224009903/form253g2.htm. Investors may also review other securities filings on the Security and Exchange Commission’s website...

Continue reading

Allied Announces March 2024 Distribution

TORONTO, March 15, 2024 (GLOBE NEWSWIRE) — Allied Properties REIT (“Allied”)(TSX:AP.UN) announced today that the Trustees of Allied have declared a distribution of $0.15 per unit for the month of March 2024, representing $1.80 per unit on an annualized basis. The distribution will be payable on April 15, 2024, to unitholders of record as at March 29, 2024. About Allied Allied is a leading owner-operator of distinctive urban workspace in Canada’s major cities. Allied’s mission is to provide knowledge-based organizations with workspace that is sustainable and conducive to human wellness, creativity, connectivity and diversity. Allied’s vision is to make a continuous contribution to cities and culture that elevates and inspires the humanity in all people. FOR FURTHER INFORMATION, PLEASE CONTACT: Cecilia C. Williams, President and...

Continue reading

SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it has entered into definitive agreements with two existing institutional investors for the purchase and sale of 13,029,316 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering and warrants to purchase up to an aggregate of 13,029,316 shares of common stock in a concurrent private placement (together with the registered direct offering, the “Offering”) at a combined purchase price of $1.535 per share and accompanying warrant, priced at-the-market under Nasdaq rules. The warrants will have an exercise...

Continue reading

Lincoln Educational Services Corporation Announces Barry Morrow’s Retirement as Chair of the Board and Names John Bartholdson as Chair following the 2024 Annual Meeting of Shareholders

PARSIPPANY, N.J., March 15, 2024 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC) today announced that J. Barry Morrow has notified the Company’s Board of Directors of his decision not to stand for re-election at the Company’s 2024 Annual Meeting of Shareholders. Mr. Morrow joined the Board in 2006 and currently serves as non-executive Chair of the Board. The Company also announced that the Board of Directors had selected current Board member John A. Bartholdson to succeed Mr. Morrow as the next Chair of the Board following the 2024 Annual Meeting of Shareholders to be held in May. Mr. Bartholdson has been a member of the Board of Directors since 2019. “The Board of Directors is extremely grateful to Barry for his leadership and dedication to this Company for all of these years and thanks him for his guidance,...

Continue reading

Seanergy Maritime Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2023 and Declares a Cash Dividend of $0.10 Per Share

Highlights          (in million USD, except EPS)   Q4 2023 Q4 2022 12M 2023 12M 2022Net revenues   $39.4 $28.5 $110.2 $125.0Net income   $10.8 $0.5 $2.3 $17.2Adjusted net income1   $11.4 $0.9 $11.9 $23.3EBITDA1   $23.3 $12.9 $51.3 $60.5Adjusted EBITDA1   $23.9 $13.3 $53.0 $66.6           Earnings per share Basic1,2   $0.55 $0.03 $0.12 $0.97Earnings per share Diluted1,2   $0.55 $0.03 $0.12 $0.96Adjusted earnings per share Basic1,2     $0.58 $0.05 $0.64 $1.32Adjusted earnings per share Diluted1,2   $0.58 $0.05 $0.64 $1.32Other Highlights and Developments:Quarterly cash dividend of $0.10 per share consisting of a regular cash dividend of $0.025 per share for Q4 2023 and a special cash dividend of $0.075 per share Total cash dividends of $1.45 per share, or $26.4 million declared since March 2022 Acquisition...

Continue reading

Healthcare Triangle, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, cybersecurity, data analytics and AI data processing for the healthcare and life sciences industries, today announced financial results for its fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial ResultsRevenue: Total revenue was $7.1 million, representing a decrease of 37% compared to the fourth quarter of 2022. Revenue from the Software Services and Managed Services segments decreased by 40% and 37%, respectively, partially offset by a 22% increase in Platform Services. GAAP loss from operations: GAAP loss from operations was $5.3 million, compared to $4.9 million...

Continue reading

Updated Financial Calendar 2024

Company announcement no. 9/2024The Interim Report Q3 2024 will be published on 7 November 2024 instead of 6 November 2024. All other dates remain unchanged.  Updated Financial Calendar for the rest of 2024: Annual General Meeting        25 April 2024Interim Report Q1                8 May 2024Interim Report Q2                22 August 2024Interim Report Q3                7 November 2024 After publication of financial statements the Company will conduct an investor presentation via a conference call and webcast. For details regarding the conference calls, please see the Company’s website: https://ir.columbusglobal.com/calendar-and-events Annual General Meeting:Columbus A/S’s annual general meeting will take place on Thursday 25 April 2024 at Lautrupvang 6, 2750 Ballerup. The meeting will start at 10.00. Ib Kunøe                        Søren...

Continue reading

Frequency Electronics Issues a Clarification to Yesterday’s Earnings Call

MITCHEL FIELD, N.Y., March 15, 2024 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM). On yesterday’s earnings call, the Company discussed program charges that adversely affected its gross margins for the quarter ended January 31, 2024. As a result of percentage of completion accounting, these charges included a temporary reversal of revenue. The Company expects to recover approximately $1.2 million of this revenue during this calendar year. Because the costs have been conservatively estimated and already charged, when this revenue is realized, the Company estimates that it will be at normal or higher than average corporate gross margins. About Frequency ElectronicsFrequency Electronics, Inc. is a world leader in the design, development and manufacture of high precision timing, frequency generation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.